The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model-Reference-Cited by-同舟云学术

The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model

Published:2007-03 Issue:2 Volume:10 Page:98-116
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Aballéa Samuel,Chancellor Jeremy,Martin Monique,Wutzler Peter,Carrat Fabrice,Gasparini Roberto,Toniolo-Neto Joao,Drummond Michael,Weinstein Milton

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference74 articles.

1. Impact of epidemic type A influenza in a defined adult population;Barker;Am J Epidemiol,1980

2. The impact of influenza epidemics on mortality: introducing a severity index;Simonsen;Am J Public Health,1997

3. The impact of influenza epidemics on hospitalizations;Simonsen;J Infect Dis,2000

4. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

5. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy;Zimmerman;Am Family Physician,1999

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of aerial logistics for immunization: a model-based evaluation of centralized storage and drone delivery of vaccines in Ghana using empirical data;SSRN Electronic Journal;2024

2. The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence;Human Vaccines & Immunotherapeutics;2023-08

3. Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model;PharmacoEconomics;2023-07-11

4. [Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy];Farmeconomia. Health economics and therapeutic pathways;2022-11-30

5. Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population?;Vaccines;2022-06-10